CasLoc logo
All Cases PTAB Litigations UPC Oppositions

ToolGen, Inc. v. Vertex Pharmaceuticals, Inc.

1:25-cv-13441

Overview

Case Number 1:25-cv-13441
Filing Date 2025-11-18
Status Litigation filed
Court District Court, D. Massachusetts (mad)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Biomay AG NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Kevin R. Mosier

Sunstein LLP

Tel: +1 (617) 443-9292

100 High Street, Boston, MA 02110

Lisa M. Tittemore

Sunstein LLP

Tel: +1 (617) 443-9292
Fax: +1 (617) 443-0004

100 High Street, 20th Floor, Boston, MA 02110

Charles River Laboratories Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

RoslinCT US Holdings, LLC NPE (Patent Assertion Entity)

Represented By

2 Attorneys Listed

Kevin R. Mosier

Sunstein LLP

Tel: +1 (617) 443-9292

100 High Street, Boston, MA 02110

Lisa M. Tittemore

Sunstein LLP

Tel: +1 (617) 443-9292
Fax: +1 (617) 443-0004

100 High Street, 20th Floor, Boston, MA 02110

Roslin Cell Therapies Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Kevin R. Mosier

Sunstein LLP

Tel: +1 (617) 443-9292

100 High Street, Boston, MA 02110

Lisa M. Tittemore

Sunstein LLP

Tel: +1 (617) 443-9292
Fax: +1 (617) 443-0004

100 High Street, 20th Floor, Boston, MA 02110

Lonza Netherlands B.V. NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Kevin R. Mosier

Sunstein LLP

Tel: +1 (617) 443-9292

100 High Street, Boston, MA 02110

Lisa M. Tittemore

Sunstein LLP

Tel: +1 (617) 443-9292
Fax: +1 (617) 443-0004

100 High Street, 20th Floor, Boston, MA 02110

Lonza Group AG Operating Company

Represented By

2 Attorneys Listed

Kevin R. Mosier

Sunstein LLP

Tel: +1 (617) 443-9292

100 High Street, Boston, MA 02110

Lisa M. Tittemore

Sunstein LLP

Tel: +1 (617) 443-9292
Fax: +1 (617) 443-0004

100 High Street, 20th Floor, Boston, MA 02110

CRISPR Therapeutics Inc. Operating Company

Represented By

1 Attorneys Listed

Joseph L. Stanganelli

Barclay Damon, LLP

Tel: +1 (617) 274-2900
Fax: +1 (617) 722-6003

160 Federal Street, Boston, MA 02110

CRISPR Therapeutics AG NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Joseph L. Stanganelli

Barclay Damon, LLP

Tel: +1 (617) 274-2900
Fax: +1 (617) 722-6003

160 Federal Street, Boston, MA 02110

Vertex Pharmaceuticals (Ireland), Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Kevin R. Mosier

Sunstein LLP

Tel: +1 (617) 443-9292

100 High Street, Boston, MA 02110

Lisa M. Tittemore

Sunstein LLP

Tel: +1 (617) 443-9292
Fax: +1 (617) 443-0004

100 High Street, 20th Floor, Boston, MA 02110

Vertex Pharmaceuticals (Europe), Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Kevin R. Mosier

Sunstein LLP

Tel: +1 (617) 443-9292

100 High Street, Boston, MA 02110

Lisa M. Tittemore

Sunstein LLP

Tel: +1 (617) 443-9292
Fax: +1 (617) 443-0004

100 High Street, 20th Floor, Boston, MA 02110

Vertex Pharmaceuticals (Canada), Incorporated Operating Company

Represented By

2 Attorneys Listed

Kevin R. Mosier

Sunstein LLP

Tel: +1 (617) 443-9292

100 High Street, Boston, MA 02110

Lisa M. Tittemore

Sunstein LLP

Tel: +1 (617) 443-9292
Fax: +1 (617) 443-0004

100 High Street, 20th Floor, Boston, MA 02110

Vertex Pharmaceuticals, Inc. Operating Company

Represented By

2 Attorneys Listed

Kevin R. Mosier

Sunstein LLP

Tel: +1 (617) 443-9292

100 High Street, Boston, MA 02110

Lisa M. Tittemore

Sunstein LLP

Tel: +1 (617) 443-9292
Fax: +1 (617) 443-0004

100 High Street, 20th Floor, Boston, MA 02110

Plaintiff

ToolGen, Inc. Operating Company

Represented By

1 Attorneys Listed

Benjamin M. Stern

Nutter, McClennen & Fish, LLP

Tel: +1 (617) 439-2142

Seaport West, 155 Seaport Boulevard

Court & Judges

Court

District Court, D. Massachusetts (mad)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US12473559
Cas9/RNA complexes for inducing modifications of target endogenous nucleic acid sequences in nucleuses of eukaryotic cells
Filed: 2023-09-15
Issued: 2025-11-18
Active (16.8 yrs remaining)
Expires: 2043-09-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

14

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 14

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
Order on Motion for Extension of Time
Entry #— • 2026-07-06
Procedural / Extension Motion Pending
Order on Motion for Leave to Appear AND Order on Motion for Leave to Appear AND Order on Motion for Leave to Appear AND Order on Motion for Leave to Appear
Entry #— • 2026-05-01
Procedural / Extension Motion Pending
Order on Motion for Extension of Time to Answer
Entry #— • 2026-05-01
Procedural / Extension Motion Pending
Order on Motion for Extension of Time to Answer
Entry #— • 2026-04-13
Procedural / Extension Motion Pending
Order on Motion for Extension of Time to Answer
Entry #— • 2026-03-31
Procedural / Extension Motion Pending
Order on Motion for Leave to File Document
Entry #— • 2026-03-26

Docket Entries

(88 total)
Pleading / Complaint

COMPLAINT against CRISPR Therapeutics AG, RoslinCT US Holdings, LLC, Vertex Pharmaceuticals (Canada), Incorporated, CRISPR Therapeutics Inc., Lonza Netherlands B.V., Vertex Pharmaceuticals, Inc., Charles River Laboratories Inc., Lonza Group AG, Vertex Pharmaceuticals (Europe), Limited, Biomay AG, Roslin Cell Therapies Limited, Vertex Pharmaceuticals (Ireland), Limited Filing fee: $ 405, receipt number AMADC-11365746 (Fee Status: Filing Fee paid), filed by ToolGen, Inc.. (Attachments: # 1 Exhibit 1 (US Patent 12,473,559 B2), # 2 Civil Cover Sheet, # 3 Category Form)(Stern, Benjamin) (Entered: 11/18/2025)

Entry #1 • 2025-11-18
1
Pleading / Complaint

COMPLAINT against CRISPR Therapeutics AG, RoslinCT US Holdings, LLC, Vertex Pharmaceuticals (Canada), Incorporated, CRISPR Therapeutics Inc., Lonza Netherlands B.V., Vertex Pharmaceuticals, Inc., Charles River Laboratories Inc., Lonza Group AG, Vertex Pharmaceuticals (Europe), Limited, Biomay AG, Roslin Cell Therapies Limited, Vertex Pharmaceuticals (Ireland), Limited Filing fee: $ 405, receipt number AMADC-11365746 (Fee Status: Filing Fee paid), filed by ToolGen, Inc.. (Attachments: # 1 Exhibit 1 (US Patent 12,473,559 B2), # 2 Civil Cover Sheet, # 3 Category Form)(Stern, Benjamin) (Entered: 11/18/2025)

Entry #1 • 2025-11-18
2
Pleading / Complaint

COMPLAINT against CRISPR Therapeutics AG, RoslinCT US Holdings, LLC, Vertex Pharmaceuticals (Canada), Incorporated, CRISPR Therapeutics Inc., Lonza Netherlands B.V., Vertex Pharmaceuticals, Inc., Charles River Laboratories Inc., Lonza Group AG, Vertex Pharmaceuticals (Europe), Limited, Biomay AG, Roslin Cell Therapies Limited, Vertex Pharmaceuticals (Ireland), Limited Filing fee: $ 405, receipt number AMADC-11365746 (Fee Status: Filing Fee paid), filed by ToolGen, Inc.. (Attachments: # 1 Exhibit 1 (US Patent 12,473,559 B2), # 2 Civil Cover Sheet, # 3 Category Form)(Stern, Benjamin) (Entered: 11/18/2025)

Entry #1 • 2025-11-18
2
Pleading / Complaint

COMPLAINT against CRISPR Therapeutics AG, RoslinCT US Holdings, LLC, Vertex Pharmaceuticals (Canada), Incorporated, CRISPR Therapeutics Inc., Lonza Netherlands B.V., Vertex Pharmaceuticals, Inc., Charles River Laboratories Inc., Lonza Group AG, Vertex Pharmaceuticals (Europe), Limited, Biomay AG, Roslin Cell Therapies Limited, Vertex Pharmaceuticals (Ireland), Limited Filing fee: $ 405, receipt number AMADC-11365746 (Fee Status: Filing Fee paid), filed by ToolGen, Inc.. (Attachments: # 1 Exhibit 1 (US Patent 12,473,559 B2), # 2 Civil Cover Sheet, # 3 Category Form)(Stern, Benjamin) (Entered: 11/18/2025)

Entry #1 • 2025-11-18
2

REPORT ON THE FILING OF AN ACTION REGARDING PATENT OR TRADEMARK. (Stern, Benjamin) (Entered: 11/18/2025)

Entry #2 • 2025-11-18
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc